Compound ID | 812
PF-987296
Class: Oxazolidinone
| Spectrum of activity: | Gram-positive |
| Details of activity: | Protein synthesis inhibitor; Effective against MRSA, VRE and PRSP |
| Description: | Harris C, Barbachyn MR, Vara Prasad JVN, et al. Identification of a new trifluorophenyl oxazolidinone, PF-987296. 46th-Intersci-Conf-Antimicrobial-Agents-Chemother 2006;213 |
| Institute where first reported: | Pfizer, US; Durata (Actavis, USA) |
| Year first mentioned: | 2006 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Reason Dropped: | No development has been reported and has been in pre-clinical trials since 2006 indicating discontinuation |
| External links: | |
| Citation: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.